Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes

Diabetes Care

Volumn 26, Issue 8, 2003, Pages 2256-2260

  Denver, Elizabeth A ^a   Barnard, Maria ^b   Woolfson, Robin G ^b   Earle, Kenneth A ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b WHITTINGTON HOSPITAL NHS TRUST   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHYLDOPA; MOXONIDINE; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; SCORING SYSTEM; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0042024830     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.8.2256     Document Type: Article

References (26)

1. Cappuccio FC, Cook DG, Atkinson RW, Wicks PD: The Wandsworth Heart and Stroke Study: a population-based survey of cardiovascular risk factors in different ethnic groups: methods and baseline findings. Nutr Metab Cardiovasc Dis 8:371-385, 1998
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: BP and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
3. Wang SL, Head J, Stevens L, Fuller JH: Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the World Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetes Care 19:305-312, 1996
4. Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44:S54-S64, 2001
5. Cutler JA, MacMahon SW, Furberg CD: Controlled clinical trials of drug treatment for hypertension: a review. Hypertension 13:136-144, 1989
6. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Programme (SHEP). JAMA 265:3255-3264, 1991
7. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 20:861-869:2001
8. Parving HH, Lenhert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P: The effect of irbersartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001
9. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICR-HOPE substudy. Lancet 355:253-259, 2000
10. National Institutes of Clinical Excellence: Management of Type 2 Diabetes-Management of Blood Pressure and Lipids (Guideline H). London, NICE, October 2002
11. The American Diabetes Association: Treatment of hypertension in adults with diabetes. Diabetes Care 26 (Suppl. 1): S80-S82, 2003
12. Colhoun HM, Dong W, Poulter NR: Blood pressure screening, management and control in England: results from the Health Survey of England 1994. J Hypertens 16:747-752, 1998
13. Winocour P: Effective diabetes care: a need for realistic targets. BMJ 324:1577-1580, 2002
14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190-1195, 1995
15. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL: Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 80:447-452, 1998
16. Anderson KM, Odell PM, Wilson PWF, Kannel WB: Cardiovascular disease risk profiles. Am Heart J 121:293-298, 1991
17. National Institute of Clinical Excellence: Management of Type 2 Diabetes: Renal Disease-Prevention and Early Management (Guideline F). London, NICE, 2002
18. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomised to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997, 2002
19. Wing LMH, Reid CN, Ryan P, Beilin LJ, Brown MA, Lennings GLR, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO West MJ: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. New Engl J Med 348:583-592, 2003
20. Pellegrini F, Belfiglio M, DeBeradis G, Franciosi M, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Corrado D, D'Ettorre A, Nicolucci A: Role of organizational factors in poor blood pressure control in patients with type 2 diabetes. Arch Intern Med 163:473-480, 2003
21. Curzio JL, Rubin PC, Kennedy SS, Reid JL: A comparison of the management of hypertensive patients by nurse practitioners compared with conventional hospital care. J Hum Hypertens 4:665-670, 1990
22. Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Fusi V, Salerno M, Zanchetti A: "To better know hypertension": educational meetings for hypertensive patients. Blood Press 9:2155-259, 2000
23. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E: Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 323:142-146, 2001
24. Berlowitz DR, Ash AA, Hickley EC, Friedman RH, Gluckman M, Kader B, Moskowitz MA: Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339:1957-1963, 1998
25. Herbert LA, Kusek JW, Greene T, Agoda LY, Jones CA, Levy AS, Breyer JA, Faubert P, Rolin HA, Wang SR: Effects of blood pressure control on progressive renal disease in blacks and whites: Modification of Diet in Renal Disease Study Group. Hypertension 30:428-435, 1997
26. U.K. Prospective Diabetes Study Group: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: BMJ 317:720-726, 1998